A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. - Wikidata - awgldk - TriplyDB

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

http://www.wikidata.org/entity/Q44527614

about

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load Non-invasive test of liver fibrosis for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosis Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B.Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?KASL clinical practice guidelines: management of hepatitis C Four-dimensional flow magnetic resonance imaging in cirrhosis.Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness.Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective.Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B Non-invasive diagnosis of liver fibrosis and cirrhosis.Diagnostic Accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex Scores in Predicting the Presence of Esophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis.Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease.Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals Management before hepatectomy for hepatocellular carcinoma with cirrhosis Hepatitis C cirrhosis: New perspectives for diagnosis and treatment Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in Chronic hepatitis C and liver fibrosis.Noninvasive assessment of portal hypertension in cirrhosis: liver stiffness and beyond.Non-invasive diagnosis of liver fibrosis in chronic hepatitis C Non-invasive prediction of forthcoming cirrhosis-related complications.Ultrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoni Novel Serum Markers of Fibrosis Progression for the Follow-Up of Hepatitis C Virus-Infected Patients New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections Hepatic steatosis and fibrosis: Non-invasive assessment.Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.Association of IFNL3 rs12979860 and rs8099917 with biochemical predictors of interferon responsiveness in chronic hepatitis C virus infection Predictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3 Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3 A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B

P2860

Q21144283-21FDBFE2-AE9F-4B3A-A794-FAFDB06408C6 Q24234751-84EA3955-6EBA-4AD9-9FE9-979FB0D224AF Q24680285-EBB54C14-30AA-4A86-9FEA-F0B5994E796F Q24816281-F90C3D98-E20C-4DA9-8142-E99A89D7EC63 Q24816554-739E2ABE-2B20-4AEC-AC09-994C10284BA9 Q26740195-050AC7DF-89F1-4A54-8191-433364DAD5DE Q26744631-03A5864F-72D0-45EF-B084-1D9A69F9FB89 Q26752471-70D21F13-8986-4B0D-B651-31E5D006CFF0 Q26769606-57224623-500B-4AC8-995D-BC9A69A90FEC Q26773187-3106794B-4BB9-4F2D-8E1C-21A821121847 Q26773289-8B1398A7-8E97-4E1E-B0C7-A4718B806A16 Q26773585-4C18195F-1C15-4744-94FC-BFFD6D157FFD Q26777916-32708F91-FE13-4284-80E9-911A83A67619 Q26778033-19617DC5-8828-4590-B011-4F9840FB06A5 Q26779866-6CAF36C8-DB24-4F47-8F84-7293E7D49A36 Q26780258-F2B1AE44-B941-43DC-8F12-99CDFD4857B4 Q26782033-E3F01945-160B-4761-A54D-8DB7BE047526 Q26783874-E9197C99-7B0E-41E9-96E3-08B59CAB63AA Q26799924-0DE4B3F3-3AC9-4C83-9A32-11ABA97E306C Q26820811-CFEC17F0-D178-4DA2-8BF5-9D37A75E1FD8 Q26825671-984C2D1D-8805-490F-ADCA-4A2BB3D326A6 Q26853160-87D83738-ED24-49BF-B91C-0E267AAB8AF2 Q26865956-AD332D3B-852A-4C46-9BB4-8F4644401840 Q27000645-323E471F-A602-410C-9717-6031D2C2BA85 Q27008387-0EC78B59-F6F1-445F-82D6-6816F236808A Q27488886-538E393C-754C-44DE-8EDA-7A7D5504E3EA Q28070168-19870359-82A0-45A4-8373-23B9595F5F94 Q28070280-37093021-E19C-4AC3-B5C0-FD176CFC6FFC Q28077200-BA802D09-CB92-4855-8E74-FFDF7549576C Q28080136-35344849-8A9E-4A8C-ABF5-A733B3B77787 Q28080225-E8726ECE-56A5-4161-AAA6-5BD50AE4F05F Q28082686-BDF5E0B0-122A-4454-A2C1-C2BE4518FA09 Q28084154-00A88B65-EFFC-4413-9AB2-828EDE8CC1F7 Q28534715-1A3AF7A2-8C1D-4303-8AB6-BDEC6F7D2A34 Q28543090-4958B9E3-83E1-4106-97B0-F4E29941823E Q28546718-2C7F1BC7-50AD-41F8-9EDF-B147664BFB1A Q28546936-0AD606EA-AA35-43A1-9B53-547193AD60F4 Q28648219-D9386355-A48B-4FEE-995F-38471BF3D163 Q28732828-81AE0089-43E9-4210-BD7F-83CCD4C1FFD8 Q28741501-50CFCEE3-068C-4C88-A1A3-668812E9631F

P2860

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

http://www.wikidata.org/entity/Q44527614

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

A simple noninvasive index can ...... ents with chronic hepatitis C.

@en

A simple noninvasive index can ...... ents with chronic hepatitis C.

@nl

type

label

A simple noninvasive index can ...... ents with chronic hepatitis C.

@en

A simple noninvasive index can ...... ents with chronic hepatitis C.

@nl

prefLabel

A simple noninvasive index can ...... ents with chronic hepatitis C.

@en

A simple noninvasive index can ...... ents with chronic hepatitis C.

@nl

P1433

Q44527614-7DC3AA04-7D18-4A5A-8A18-A0FFA85EE298

P1476

Q44527614-FF68425E-47EE-4E6D-BFCD-E0E8BFABF1A7

P2093

Q44527614-14CCB6D7-495E-4E71-A71C-9609F7825D6F

Q44527614-422781D8-0EC3-4C32-9C80-5FF976ADA307

Q44527614-483B84B0-F4AB-496E-AA99-777F2186A933

Q44527614-51BE555A-5940-44D5-92F3-566517BBA991

Q44527614-A72D7012-F9F6-40D4-AE88-43FF601FB7F7

Q44527614-E27F9B25-18F7-4AE4-ADA4-2AC4C016AC89

Q44527614-EFB3B16E-4C9B-47C9-85F3-314E67154F7B

P304

Q44527614-8832FA7B-C8FA-45DB-94E7-9F77A8FC1B77

P31

Q44527614-02845613-40B8-49B7-B6B0-74886B7EF1A0

P356

Q44527614-465B750D-DCA0-4944-BDB1-C6973867E47C

P407

Q44527614-D6F9D040-6CC2-4AC0-AF32-AFE649E222BD

P433

Q44527614-51B5150A-A1C7-4F33-9200-0EB20B120290

P478

Q44527614-05F910A5-CA4C-4C3A-BA5C-21A3C3623717

P577

Q44527614-AF2606F2-4589-43C7-B5C7-2790BEFD34B4

P5875

Q44527614-3C4B3958-A336-4C65-B05F-D9DE2A3121AC

P698

Q44527614-12A9AE08-5AD6-425D-8680-3FB10B9D8D0B

P921

Q44527614-61F3E04B-2669-4FAE-9712-F0082121289A

Q44527614-89A8487F-022E-48FB-B9EF-1E0804A102E1

P356

JHEP.2003.50346

P1433

P1476

A simple noninvasive index can ...... ents with chronic hepatitis C.

@en

P2093

Anna S-F Lok

http://www.w3.org/2001/XMLSchema#string

Chun-Tao Wai

http://www.w3.org/2001/XMLSchema#string

Hari S Conjeevaram

http://www.w3.org/2001/XMLSchema#string

Joel K Greenson

http://www.w3.org/2001/XMLSchema#string

John D Kalbfleisch

http://www.w3.org/2001/XMLSchema#string

Jorge A Marrero

http://www.w3.org/2001/XMLSchema#string

Robert J Fontana

http://www.w3.org/2001/XMLSchema#string

P304

518-526

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/JHEP.2003.50346

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10641548

http://www.w3.org/2001/XMLSchema#string

P698

12883497

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis